ConceptTheory & Algos
GLP-1 agonists in neurodegeneration
The testing of glucagon-like peptide-1 receptor agonists as potential treatments for Alzheimer's and Parkinson's diseases.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Metabolic pathway1Pharmacology1
Lecturers
1Connections
2The lectures that define it or assume it, and the concepts next to it.